Fig. (2) Drugs used for GAD treatment at basal and 6 month visits. A) DSM-IV criteria group. B) Broaden criteria group. Data presented as percentage of patients in each group.Differences not significant when not indicated. All changes, except for other, were statistically significant when compared to the baseline visit (p<0.001 in all cases). # p< 0.05, † p<0.01 and ‡ p<0.001 when comparing DSM-IV and broad criteria groups in both visits.